Adelipour Maryam, Naghashpour Mahshid, Roshanazadeh Mohammad Reza, Chenaneh Hadi, Mohammadi Asma, Pourangi Pegah, Miri Seyed Rouhollah, Zahedi Atefeh, Haghighatnezhad Mahmood, Golabi Sahar
Department of Biochemistry, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Department of Nutrition, School of Medicine, Abadan University of Medical Science, Abadan, Iran.
Mol Biol Res Commun. 2024;13(1):11-19. doi: 10.22099/mbrc.2023.47597.1837.
Autophagy is a cellular process that plays a major role in the fate of tumor cells. Understanding the role of autophagy in cancer therapy is a major challenge, particularly for breast cancer as the sole top cause of mortality among women. In this study, we evaluated the gene expression of and and the levels of p62 protein, in breast tumors and compared them to a control condition. To explore the role of autophagy in breast cancer, we acquired tumor biopsies from 41 new cases of breast cancer patients. We extracted total RNA from each biopsy and used real-time PCR to quantify and -specific RNA expression. In addition, we evaluated the expression of the p62 protein in paraffin-embedded tumor tissue using the immunohistochemistry technique. The data revealed an upregulation of and a downregulation of in tumor tissues compared to the control condition. The correlation between p62 expression and / showed a negative and positive correlation, respectively, confirming autophagy activation in the tumor tissues. However, there was no correlation between autophagy markers and tumor size, grade and stage. The findings revealed that autophagy activation was found in breast tumor tissues, suggesting that autophagy can be a target for breast cancer therapy.
自噬是一种在肿瘤细胞命运中起主要作用的细胞过程。了解自噬在癌症治疗中的作用是一项重大挑战,对于乳腺癌而言尤其如此,因为乳腺癌是女性死亡的唯一首要原因。在本研究中,我们评估了乳腺癌组织中[具体基因名称1]和[具体基因名称2]的基因表达以及p62蛋白水平,并将它们与对照情况进行比较。为了探究自噬在乳腺癌中的作用,我们从41例新确诊的乳腺癌患者中获取了肿瘤活检样本。我们从每个活检样本中提取总RNA,并使用实时PCR定量[具体基因名称1]和[具体基因名称2]特异性RNA的表达。此外,我们使用免疫组织化学技术评估石蜡包埋肿瘤组织中p62蛋白的表达。数据显示,与对照情况相比,肿瘤组织中[具体基因名称1]上调,[具体基因名称2]下调。p62表达与[具体基因名称1]/[具体基因名称2]之间分别呈负相关和正相关,证实肿瘤组织中存在自噬激活。然而,自噬标志物与肿瘤大小、分级和分期之间没有相关性。研究结果表明,在乳腺肿瘤组织中发现了自噬激活,这表明自噬可以成为乳腺癌治疗的一个靶点。